Concord Biosciences

Concord Biosciences is a contract research organization (CRO) specializing in preclinical safety assessment and drug metabolism services. Headquartered in Concord, Ohio, the company provides a broad suite of services including general toxicology, developmental and reproductive toxicology, and bioanalytical testing. The organization was formerly the preclinical division of Ricerca Biosciences before being rebranded as Concord Biosciences. In April 2018, the company was acquired by Frontage Laboratories, a move that significantly enhanced Frontage's capacity for safety and metabolism studies in North America. Today, the entity operates as a key site within Frontage's global network, continuing to serve pharmaceutical, biotech, and agrochemical clients.